GDRX — Goodrx Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $2.60bn
- $2.58bn
- $750.27m
- 91
- 20
- 89
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 66 | -294 | -25.3 | -32.8 | -8.87 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 14.2 | 450 | 168 | 146 | 127 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.82 | -32.5 | -11.8 | -20.3 | -21.9 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 83.3 | 131 | 179 | 147 | 138 |
Capital Expenditures | -5.75 | -35.8 | -34.5 | -55.2 | -55.8 |
Purchase of Fixed Assets | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | -31.3 | -55.8 | -144 | -155 | 0 |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -37.1 | -91.6 | -179 | -210 | -55.8 |
Financing Cash Flow Items | -2.21 | 15 | -58.5 | -20.6 | -64.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -54.8 | 906 | -30.5 | -120 | -167 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.55 | 946 | -30.5 | -184 | -84.9 |